Systematic review and meta-analysis: Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 1, 2006, Pages 35-44

  Gisbert, J P ^a,b   De La Morena, F ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BISMUTH; CLARITHROMYCIN; ESOMEPRAZOLE; FURAZOLIDONE; LANSOPRAZOLE; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; RIFABUTIN; TETRACYCLINE; TINIDAZOLE;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA EXTRACTION; DATA SYNTHESIS; DRUG EFFICACY; DRUG TOLERABILITY; ELECTRONICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; PEPTIC ULCER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OFLOXACIN; TREATMENT FAILURE;

EID: 33644925601     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02737.x     Document Type: Review

References (41)

1. Gisbert JP Pajares JM Review article: Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail Aliment Pharmacol Ther 2002 16 1047 57
2. Gisbert JP Boixeda D Bermejo F et al. Re-treatment after Helicobacter pylori eradication failure Eur J Gastroenterol Hepatol 1999 11 1049 54
3. Elizalde IR Borda F Jara C Martínez A Rodríguez C Jiménez J Eficacia de dos tratamientos consecutivos en la erradicación de Helicobacter pylori Anales Sis San Navarra 1998 21 Suppl. 2 83 88
4. Gomollon F Ducons JA Ferrero M et al. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases Helicobacter 1999 4 222 5
5. Gasbarrini A Ojetti V Pitocco D et al. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus Scand J Gastroenterol 2000 35 260 3
6. Lee JM Breslin NP Hyde DK Buckley MJ O'Morain CA Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice Aliment Pharmacol Ther 1999 13 489 96
7. Gisbert JP Gisbert JL Marcos S Gravalos RG Carpio D Pajares JM Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole Aliment Pharmacol Ther 1999 13 1311 6
8. Perri F Festa V Clemente R et al. Randomized study of two 'rescue' therapies for Helicobacter pylori- infected patients after failure of standard triple therapies Am J Gastroenterol 2001 96 58 62
9. Sicilia B Sierra E Lago A Villar M Garcia S Gomollon F High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy Med Clin (Barc) 2000 115 641 3
10. Baena Diez JM Lopez Mompo C Rams Rams F Garcia Lareo M Rosario Hernandez Ibanez M Teruel Gila J Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of a combination of omeprazole, clarithromycin and amoxycillin Med Clin (Barc) 2000 115 617 9
11. Michopoulos S Tsibouris P Bouzakis H et al. Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens Aliment Pharmacol Ther 2000 14 737 44
12. Croom KF Goa KL Levofloxacin: a review of its use in the treatment of bacterial infections in the United States Drugs 2003 63 2769 802
13. Gisbert JP Pajares JM Helicobacter pylori'rescue' therapy after failure of two eradication treatments Helicobacter 2005 10 363 72
14. Jadad AR Moore RA Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary Control Clin Trials 1996 17 1 12
15. Cammarota G Martino A Pirozzi G et al. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection Aliment Pharmacol Ther 2004 19 789 95
16. Miehlke S Madisch A Bästlein E et al. One-week triple theraphy with esomeprazole, levofloxacin and amoxicillin is effective for eradication of Helicobacter pylori sensitive or resistant to metronidazole and/or clarithromycin Helicobacter 2003 8 464
17. Oksanen AM Rautelin H Levofloxacin combination therapy for clamithromycin and metronidazole resistant Helicobacter pylori strains Helicobacter 2003 8 476
18. Gatta L Zullo A Perna F et al. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses Aliment Pharmacol Ther 2005 22 45 9
19. Perri F Festa V Merla A Barberani F Pilotto A Andriulli A Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy' Aliment Pharmacol Ther 2003 18 815 20
20. Gisbert JP Perez-Aisa A Castro-Fernandez M et al. Rescue therapy with levofloxacin after multiple H. pylori treatment failures Helicobacter 2005 10 531
21. Gisbert JP Gisbert JL Marcos S Olivares D Pajares JM 7-day ranitidine bismuth citrate- vs. levofloxacin-based triple theraphy after H. pylori treatment failure Helicobacter 2005 10 533
22. Orsi P Pinazzi O Aragona G Di Mario F Rabeprazole/levofloxacin based triple therapy as a salvatage treatment after failure of H. pylori eradication with standard regimens Helicobacter 2003 8 339 493
23. Matsumoto Y Nobuo A Iyuka M et al. A High Dosage of Levofloxacin- vs. Metronidazole-based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy in Japan Gastroentorology 2005 128 T963
24. Watanabe Y Aoyama N Shirasaka D et al. Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy Dig Liver Dis 2003 35 711 5
25. Zullo A Hassan C De Francesco V et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication Dig Liver Dis 2003 35 232 6
26. Bilardi C Dulbecco P Zentilin P et al. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial Clin Gastroenterol Hepatol 2004 2 997 1002
27. Nista EC Candelli MMS et al. Levofloxacin-based triple theraphy in second-line treatment for H. pylori eradication: update Gastroenterology 2005 128 427
28. Nista EC Candelli M Cremonini F et al. Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial Aliment Pharmacol Ther 2003 18 627 33
29. Nista EC Candelli M Fini L et al. 10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication Gastroenterology 2004 126 576
30. Wong WM Gu Q Lam SK et al. Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection Aliment Pharmacol Ther 2003 17 553 60
31. Coelho LG Moretzsohn LD Vieira WL et al. New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study Aliment Pharmacol Ther 2005 21 783 7
32. Malfertheiner P Megraud F O'Morain C et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report Aliment Pharmacol Ther 2002 16 167 80
33. Lam SK Talley NJ Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection J Gastroenterol Hepatol 1998 13 1 12
34. Gisbert JP Calvet X Gomollon F Mones J Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference Med Clin (Barc) 2005 125 301 16
35. Sanchez JE Saenz NG Rincon MR Martin IT Sanchez EG Martinez MJ Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones J Antimicrob Chemother 2000 46 283 5
36. Xia HH Yu Wong BC Talley NJ Lam SK Alternative and rescue treatment regimens for Helicobacter pylori eradication Expert Opin Pharmacother 2002 3 1301 11
37. Zou J Yang ZX Qin ZM Laboratory and clinical study of levofloxacin against Helicobacter pylori Zhonghua Yi Xue Za Zhi 2003 83 1778 81
38. Tanaka M Isogai E Isogai H et al. Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori J Antimicrob Chemother 2002 49 1039 40
39. Gisbert JP Pajares JM Helicobacter pylori therapy: first-line options and rescue regimen Dig Dis 2001 19 134 43
40. Cabrita J Oleastro M Matos R et al. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) J Antimicrob Chemother 2000 46 1029 31
41. Gisbert JP Rescue therapy with levofloxacin after multiple H. pylori treatment failures Aliment Pharmacol Ther 2005 22 653 4